EndoSheath在软性膀胱镜检查中的应用:超过1000例的前瞻性评估
这项前瞻性单中心研究评估了1091例EndoSheath辅助软性膀胱镜检查(eFC)的耐受性与安全性,以尿路感染(UTI)为替代指标。结果显示33.2%无不适、48.2%轻度不适,仅3.1%为重度不适;总体eFC后UTI发生率为13.3%,女性(18.1%)高于男性(11.2%),≥65岁者(15.4%)高于<65岁者(8.8%),无尿脓毒症发生。结论认为eFC耐受性良好且安全。
要点
- 1091例eFC中33.2%无不适、48.2%轻度不适,仅3.1%为重度不适。
- 总体eFC后UTI发生率为13.3%,女性18.1%高于男性11.2%。
- ≥65岁者UTI发生率15.4%高于<65岁者8.8%,无尿脓毒症发生。
核心结论
- 这项大型、前瞻性、非选择性的真实世界研究报告eFC耐受性良好。
- 女性及≥65岁者UTI发生率更高,与采用同样宽泛UTI诊断标准的其他研究一致。
- 结论认为eFC既耐受性良好又安全。
研究设计与样本
- 前瞻性评估单中心26个月期间所有接受eFC的成年患者。
- 共分析1091例eFC。
- eFC后参与者用视觉模拟量表评定不适(1=无,2-4=轻度,5-7=中度,8-10=重度)。
- UTI诊断宽泛,基于患者自报、尿培养阳性或eFC后30天内抗生素处方中任一项。
- 数据分析使用卡方检验(P<0.05,双尾)。
主要发现
- 1091例eFC中,33.2%被评为无不适,48.2%为轻度不适,仅3.1%为重度不适。
- 年轻参与者不适更重,但性别间相似。
- 总体eFC后UTI发生率为13.3%,女性(18.1%)高于男性(11.2%)。
- ≥65岁参与者UTI发生率(15.4%)高于<65岁者(8.8%)。
- 无参与者发生尿脓毒症。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate patient tolerability and safety (using urinary tract infection (UTI) as a proxy measure) following EndoSheath-assisted flexible cystoscopy (eFC). EndoSheaths are single-use, disposable sheaths used in FC. They reduce cystoscope turnaround times as complicated, time-consuming and costly sterilisation is no longer necessary. This reduces patient waiting times as cystoscope idle time, the most common rate limiting step, is reduced. PATIENTS AND METHODS: All adult patients undergoing eFC over a 26-month period at a single institution were evaluated prospectively. Post-eFC, participants rated discomfort on a visual analogue scale (discomfort 1 = none, 2-4 = mild, 5-7 = moderate, 8-10 = severe). The diagnosis of UTI was broad and based on any one of patient self-report, positive urine culture or antibiotic prescription within 30 days of eFC. Data were analysed using chi-squared testing (P < 0.05, two-tailed). RESULTS: Of the 1091 eFCs analysed, 33.2% and 48.2% of were ranked as causing no or mild discomfort, respectively, with just 3.1% ranked severe. Discomfort was greater in younger participants but similar between sexes. Overall, post-eFC UTI incidence was 13.3%, with rates higher in females (18.1%) than males (11.2%). Participants aged ≥65 years reported a higher UTI rate (15.4%) than those aged <65 years (8.8%). No participants developed urosepsis. CONCLUSION: This large, prospective, unselected, real-world study reports that eFC is well tolerated. UTI was higher in females than males, and in those aged ≥65 years, in line with other studies using the same broad based diagnostic criteria for UTI. The conclusion is that eFC is both well tolerated and safe.
引用
- Ratcliffe L, Birch B. EndoSheath use in flexible cystoscopy: a prospective evaluation of >1000 cases. BJU Int. 2024. PMID: 39532306. doi:10.1111/bju.16578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。